James Maitland is a distinguished authority on the intersection of healthcare technology and public policy, with a career dedicated to the integration of robotics and IoT in medical settings. His expertise offers a window into how large-scale data and operational systems function within the complex landscape of American healthcare programs. Today, he joins us to discuss the growing tensions between federal regulators and state Medicaid directors, providing a critical look at the current disputes over program integrity and the financial stability of the nation’s safety net.
The following conversation navigates the heated controversy surrounding the CMS’s decision to withhold billions in funding from several states under the banner of fraud prevention. Maitland delves into the specific financial deferrals affecting California and Minnesota, the factual errors that have plagued federal assessments in New York, and the broader political implications of these enforcement actions. He also highlights the proactive measures states are taking to secure their programs and the potential risks these funding gaps pose to the 75 million Americans who depend on Medicaid for their essential healthcare needs.
California is currently facing the largest funding deferral in the history of the CMS, totaling $1.3 billion, primarily due to concerns over home-based care growth. How do you interpret the federal government’s stance compared to the state’s actual policy goals?
This is a fascinating and troubling clash between federal oversight and state-level innovation in care delivery. California’s Medicaid director, Tyler Sadwith, has been very clear that the rapid growth in these services was an intentional, strategic move to pivot away from expensive institutional care and toward more convenient home-based support for seniors and the disabled. While the CMS under Dr. Oz points to this growth as evidence of “snowballing fraud,” the state argues they were already in deep discussions with federal partners to explain these drivers before the money was ever yanked. To see a $1.3 billion freeze without any specific instances of abuse being cited suggests a breakdown in the collaborative spirit that usually defines the relationship between the CMS and the states. From my perspective in medical technology, expanding home care is a vital step toward sustainable health, and California has even suspended approximately 5,000 providers and recovered over $1 billion in fraudulent payments over the last three years to protect that transition.
Minnesota has also seen a significant portion of its funding paused, with $350 million on the line. What does this situation tell us about the predictability of federal oversight for state programs?
The situation in Minnesota is a textbook example of “shifting goalposts,” which makes long-term state budgeting nearly impossible. John Connolly has expressed deep frustration because the state actually had a corrective action plan accepted by the CMS earlier this year, which should have been the green light they needed to move forward and resolve the threat of a $2 billion annual withhold. Instead, they are left wondering when—or if—that $350 million will be released, even as they face a structural budget deficit that has plagued them for a few years now. It’s important to note that Minnesota hasn’t been sitting on its hands; they’ve conducted more than 3,000 investigations and recovered $50 million since 2020 alone. When federal regulators add these layers of pressure and risk without a clear path to resolution, it doesn’t just hurt the state’s balance sheet—it threatens the very benefits and payment levels for providers that keep the program functioning.
There was a major discrepancy in New York where the CMS claimed 5 million people used personal care services, though the state says the real number is 450,000. How does such a massive error impact the legitimacy of the federal government’s fraud-fighting narrative?
It’s honestly hard to overstate how damaging that mistake was to the CMS’s credibility in this particular debate. When you claim that 75% of a state’s Medicaid population is utilizing a specific service when the actual figure is closer to 5%, you aren’t just slightly off—you are fundamentally misreading the reality on the ground. Amir Bassiri, the director in New York, had to correct the record during a period of intense scrutiny, and while the CMS eventually admitted the error, it gave a lot of weight to the argument that these investigations are more about “political theater” than actual data-driven enforcement. New York has already been quite aggressive in its own right, performing 2,500 audits in 2024 and generating $4.5 billion in savings and recoveries. When federal leaders “attack first and ask questions later” based on faulty numbers, it suggests that the goal might be more about manufacturing a basis for conflict than actually rooting out the 450 clinical matters they referred for prosecution last year.
How significant is the shift in the CMS’s aggressive approach under the current administration compared to how these federal-state partnerships operated in the past?
We are seeing a complete departure from the status quo, transitioning from a collaborative model to one that feels much more adversarial. Historically, the CMS worked hand-in-hand with state attorneys general and Medicaid fraud units to address vulnerabilities, but now we are seeing threats of decertification and the establishment of a federal fraud-fighting task force by executive order. This spring, all 50 states were essentially told to re-audit every single provider deemed at risk, and Hawaii has already seen its fraud control unit decertified. This new aggressiveness is particularly jarring for state directors because it bypasses the usual notice periods and joint reviews. While Republicans like Brett Guthrie argue this is a necessary response to “rampant fraud,” the fact that billions in funding deferrals have only hit blue states so far makes it difficult for many to see this as a purely objective enforcement of federal standards, especially given the president’s own blizzard of pardons for people convicted of fraud.
Beyond the numbers and the political back-and-forth, what are the human risks involved when Medicaid funding is deferred or withheld without warning?
This is where the debate becomes very real for the 75 million low-income Americans who rely on this safety net. We aren’t just talking about abstract numbers on a spreadsheet; we are talking about a resident in Minnesota who might experience a gap in treatment or a senior in California whose support services are suddenly interrupted. John Connolly made a powerful point that a missed appointment can quickly turn into a full-blown crisis for someone with significant medical needs. When states have to scramble to cover a $1.3 billion or $350 million shortfall, it puts immense pressure on every part of the system, from eligibility levels to the transportation services that get people to their doctors. States are already trying to secure high-risk areas like hospice care and non-emergency medical transportation, having removed nearly 800 providers in New York alone for concerns over fake claims, but you can’t protect program integrity by putting the beneficiaries themselves in harm’s way as “collateral damage.”
What is your forecast for the future of Medicaid program integrity and federal-state relations?
I expect that the next several years will be defined by a significant increase in legal challenges and a more defensive posture from state governments. The precedent of withholding billions of dollars without clear criteria or prior notice has broken a level of trust that is essential for the effective administration of a program as large as Medicaid. We will likely see states doubling down on their own internal tracking and monitoring systems—like those being used to oversee the providers California has suspended—to prove their diligence before the CMS even asks. However, unless there is a return to a data-first, collaborative approach, the friction between federal regulators and state directors will only intensify, potentially creating a fragmented system where the quality of care and the stability of funding depend more on a state’s political alignment than on the actual health needs of its citizens.
